spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search    

The fully linked HTML version of this article has now been published.
JCS ePress online publication date 15 Jan 2008
doi: 10.1242/jcs.017145

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.017145v1
121/3/358    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, W. B.
Right arrow Articles by Chen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, W. B.
Right arrow Articles by Chen, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism


Wei Bin Fang, Reneé C. Ireton, Guanglei Zhuang, Takamune Takahashi, Al Reynolds, and Jin Chen*
* Author for correspondence (e-mail: jin.chen{at}vanderbilt.edu)

EPHA2 receptor tyrosine kinase is overexpressed in several human cancer types and promotes malignancy. However, the mechanisms by which EPHA2 promotes tumor progression are not completely understood. Here we report that overexpression of a wild-type EPHA2, but not a signaling-defective cytoplasmic truncation mutant ({Delta}C), in human mammary epithelial cells weakens E-cadherin-mediated cell-cell adhesion. Interestingly, the total level of cadherins and the composition of the adherens junction complexes were not affected, nor was the tyrosine phosphorylation of the cadherin complex components changed. By contrast, RhoA GTPase activity was significantly affected by modulating the EPHA2 activity in MCF-10A cells. Treatment with a ROCK kinase inhibitor rescued cell-cell adhesion defects in EPHA2-overexpressing cells, whereas expression of constitutively activated Rho disrupted adherens junctions in {Delta}C-expressing cells. EPHA2-dependent Rho activation and destabilization of adherens junctions appeared to be regulated via a signaling pathway involving Src kinase, low molecular weight phosphotyrosine phosphatase (LMW-PTP) and p190 RhoGAP. EPHA2 interacted with both Src and LMW-PTP, and the interactions increased in EPHA2-overexpressing cells. In addition, LMW-PTP phosphatase activity was elevated, and this elevation was accompanied by a decrease in tyrosine phosphorylation of p190 RhoGAP and destabilization of cell-cell adhesion. Expression of either a dominant negative LMW-PTP mutant, C12S, or a wild-type p190 RhoGAP rescued adhesion defects in EPHA2-overexpressing cells. Together, these data suggest that EPHA2 promotes tumor malignancy through a mechanism involving RhoA-dependent destabilization of adherens junctions.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. A. Cercone, W. Schroeder, S. Schomberg, and T. C. Carpenter
EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia
Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L856 - L863.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis
Mol. Cancer Res., July 1, 2009; 7(7): 1021 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Leroy, C. Fialin, A. Sirvent, V. Simon, S. Urbach, J. Poncet, B. Robert, P. Jouin, and S. Roche
Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells
Cancer Res., March 15, 2009; 69(6): 2279 - 2286.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
X. Huang, D. Wu, H. Jin, D. Stupack, and J. Y.J. Wang
Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling
J. Cell Biol., November 17, 2008; 183(4): 711 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Larson, S. Schomberg, W. Schroeder, and T. C. Carpenter
Endothelial EphA receptor stimulation increases lung vascular permeability
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L431 - L439.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. B. Fang, D. M. Brantley-Sieders, Y. Hwang, A.-J. L. Ham, and J. Chen
Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase
J. Biol. Chem., June 6, 2008; 283(23): 16017 - 16026.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
W. B. Fang, R. C. Ireton, G. Zhuang, T. Takahashi, A. Reynolds, and J. Chen
Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism
Development, February 15, 2008; 135(4): e1 - e1.
[Full Text]


© The Company of Biologists Ltd 2008